Table 2.
Kidney | Circulation | Coagulation | Lung | Brain | Infections |
---|---|---|---|---|---|
Assess AKI severity using ICA Criteria * Taper/withdraw from diuretics and beta-blockers, withdraw from nephrotoxic drugs | Assess hemodynamic state early; consider a MAP ≥ 65 mmHg as target | Assess complete blood count and coagulation tests | Assess respiratory state by using also imaging techniques Calculate PaO2/FiO2 or SpO2/FiO2 | Assess hepatic encephalopathy using West Haven criteria. Identify and treat the underlying cause | Perform a complete work up for infection at ACLF diagnosis |
Administer albumin (1 g/kg for 48 h) if AKI stage > 1a * to volume expansion; if HRS-AKI, administer terlipressin by continuos infusion (2 mg/24 h) and albumin (20/40 g/day) | Administer crystalloids and 5% albumin as resuscitation fluids; norephinephrine as first line vasopressor |
Administer platelets (if < 20.000 × 109/L) and fibrinogen (if <1 g/L) if invasive procedures | Administer oxygen and ventilation with lung protective strategy | Administer lactulose and enemas for hepatic encephalopathy. | Administer broad spectrum high-dose antibiotics at ACLF diagnosis and frequently re-assess therapy |
Consider RRT as bridge to LT | Consider 20% albumin if AKI (see Kidney), SBP, LVP; consider terlipressin if additional agent needed | Consider prophylaxis for DVT in patients without severe coagulopathy | Consider intubation if risk of aspiration (West Haven grade III or IV hepatic encephalopathy) | Consider short-acting sedative agents if necessary | Consider antifungal agents if risk factors for fungal infections |
Avoid NSAIDs | Avoid starches | Avoid fresh frozen plasma to correct INR if no bleeding | Avoid delay in intubation even if normal blood oxygen level | Avoid deep sedation and benzodiazepines | Avoid delay in antibiotics administration |
* See ref. [34].